Russian Federation
Moskva, Russian Federation
UDC 61
The article discusses the relationship between diabetes mellitus and stomach cancer, as well as the impact of metformin on the prognosis of patients with these conditions. Most studies suggest that patients with diabetes mellitus have an increased risk of developing stomach cancer. Patients with diabetes mellitus and stomach cancer are more likely to experience complications after gastrectomy, and their prognosis may be worse than that of patients without diabetes mellitus. However, patients with diabetes mellitus and stomach cancer may experience improved glycemic control after gastrectomy. The association between diabetes mellitus and gastric cancer may be due to common risk factors such as hyperglycemia, poor diet, smoking, Helicobacter pylori infection, and the use of certain medications, such as insulin, metformin, statins, aspirin, and proton pump inhibitors. Some studies suggest that the use of metformin may reduce the risk of gastric cancer in patients with type 2 diabetes mellitus. This is supported by numerous in vitro and animal model studies. Metformin can also reduce the risk of Helicobacter pylori infection, which is an important risk factor for stomach cancer. Additionally, metformin has been shown to improve survival rates and reduce the incidence of recurrence in patients with stomach cancer.
diabetes, gastric cancer, gastrectomy, Helicobacter pylori, metformin
1. van Baar A. C. G., Holleman F., Crenier L., et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Gut. 2020;69(2):295–303. doi:https://doi.org/10.1136/gutjnl-2019-318349.
2. Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, Pu J, Lv J. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023 Apr 28;29(16):2452-2468. doi:https://doi.org/10.3748/wjg.v29.i16.2452.
3. Wang L, Zhang Z. Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms. J Diabetes Res. 2023 Nov 9;2023:4388437. doi:https://doi.org/10.1155/2023/4388437.
4. Rojas A, Lindner C, Schneider I, Gonzàlez I, Araya H, Morales E, Gómez M, Urdaneta N, Araya P, Morales MA. Diabetes mellitus contribution to the remodeling of the tumor microenvironment in gastric cancer. World J Gastrointest Oncol. 2021 Dec 15;13(12):1997-2012. doi:https://doi.org/10.4251/wjgo.v13.i12.1997.
5. Kang YL, Kim J, Kwak SB, Kim YS, Huh J, Park JW. The polyol pathway and nuclear ketohexokinase A signaling drive hyperglycemia-induced metastasis of gastric cancer. Exp Mol Med. 2024 Feb;56(1):220-234. doi:https://doi.org/10.1038/s12276-023-01153-3.
6. Guo J, Liu C, Pan J, Yang J. Relationship between diabetes and risk of gastric cancer: A systematic review and meta-analysis of cohort studies. Diabetes Res Clin Pract. 2022 May;187:109866. doi:https://doi.org/10.1016/j.diabres.2022.109866.
7. De la Torre K, Song M, Abe SK, Rahman MS, Islam MR, Saito E, Min S, Huang D, Chen Y, Gupta PC, Sawada N, Tamakoshi A, Shu XO, Wen W, Sakata R, Kim J, Nagata C, Ito H, Park SK, Shin MH, Pednekar MS, Tsugane S, Kimura T, Gao YT, Cai H, Wada K, Oze I, Shin A, Ahn YO, Ahsan H, Boffetta P, Chia KS, Matsuo K, Qiao YL, Rothman N, Zheng W, Inoue M, Kang D. Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants. J Diabetes. 2024 Jun;16(6):e13561. doi:https://doi.org/10.1111/1753-0407.13561.
8. Yang HJ, Kang D, Chang Y, Ahn J, Ryu S, Cho J, Guallar E, Sohn CI. Diabetes mellitus is associated with an increased risk of gastric cancer: a cohort study. Gastric Cancer. 2020 May;23(3):382-390. doi:https://doi.org/10.1007/s10120-019-01033-8.
9. Scherübl H. [Type-2-diabetes and cancer risk] Dtsch Med Wochenschr. 2021 Sep;146(18):1218-1225. doi:https://doi.org/10.1055/a-1529-4521.
10. Zádori N, Szakó L, Váncsa S, Vörhendi N, Oštarijaš E, Kiss S, Frim L, Hegyi P, Czimmer J. Six Autoimmune Disorders Are Associated With Increased Incidence of Gastric Cancer: A Systematic Review and Meta-Analysis of Half a Million Patients. Front Immunol. 2021 Nov 23;12:750533. doi:https://doi.org/10.3389/fimmu.2021.750533.
11. Chen X, Chen Y, Li T, Liang W, Huang H, Su H, Sui C, Hu Y, Chen H, Lin T, Chen T, Zhao L, Liu H, Li G, Yu J. Diabetes mellitus promoted lymph node metastasis in gastric cancer: a 15-year single-institution experience. Chin Med J (Engl). 2022 Apr 20;135(8):950-961. doi:https://doi.org/10.1097/CM9.0000000000001795.
12. Sheng L, Peng H, Pan Y, Wang C, Zhu Y. Evaluating the effect of diabetes on the prognosis of gastric cancer using a propensity score matching method. J Gastrointest Oncol. 2020 Oct;11(5):999-1008. doi:https://doi.org/10.21037/jgo-20-375.
13. Shin S, Kim MH, Oh CM, Ha E, Ryoo JH. Association Between Type 1 Diabetes Mellitus and Incident Gastrointestinal Cancer in Korean Population: A Nationwide Retrospective Cohort Study. Diabetes Metab Res Rev. 2024 Oct;40(7):e3848. doi:https://doi.org/10.1002/dmrr.3848.
14. Han KH, Choi YJ, Il Kim T, Park NH, Han KD, Lee DH. Association between glycemic status and the risk of gastric cancer in pre/peri-and postmenopausal women: A nationwide cohort study. Ann Epidemiol. 2024 Jun;94:106-112. doi:https://doi.org/10.1016/j.annepidem.2024.04.009.
15. Choi M, Lee WR, Han KT, Kim W. The impact of physical disability on the risk of gastric cancer incidence in elderly patients with diabetes: a focus on regional disparity. Cancer Causes Control. 2024 Apr;35(4):705-710. doi:https://doi.org/10.1007/s10552-023-01840-6.
16. An N, Zhang Y, Sha Z, Xu Z, Liu X. T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis. Front Oncol. 2024 Jun 14;14:1327154. doi:https://doi.org/10.3389/fonc.2024.1327154.
17. Ma J, Gao Y, Hou S, Cui S, Zhu J. Mendelian Randomization and Transcriptome Data Analysis Reveal Bidirectional Causal Relationships and Mechanisms between Type 2 Diabetes and Gastric Cancer. Curr Med Chem. 2025;32(21):4284-4310. doi:https://doi.org/10.2174/0109298673348645241226091059.
18. Wang X, Zhu L, Liu Z, Man C, Gao Z, Gong D, Fan Y. Association between type 2 diabetes and gastric cancer in Europeans and East Asians based on two sample Mendelian randomization. Discov Oncol. 2025 Apr 17;16(1):549. doi:https://doi.org/10.1007/s12672-025-02317-5.
19. Zhao J, Li W, Chen L, Li M, Deng W. Casual effects of type 1 diabetes mellitus on site-specific digestive cancers: a Mendelian randomisation analysis. Front Endocrinol (Lausanne). 2024 Sep 5;15:1407329. doi:https://doi.org/10.3389/fendo.2024.1407329.
20. Bae JM. Diabetes History and Gastric Cancer Risk: Different Results by Types of Follow-Up Studies. Asian Pac J Cancer Prev. 2022 May 1;23(5):1523-1528. doi:https://doi.org/10.31557/APJCP.2022.23.5.1523.
21. Ahn SM, Hyung WJ. Beneficial effects of proximal intestinal bypass reconstruction on glucose metabolism in a type 2 diabetes animal model: a possible reconstruction strategy for diabetic gastric cancer patients. Ann Surg Treat Res. 2021 Apr;100(4):218-227. doi:https://doi.org/10.4174/astr.2021.100.4.218.
22. Cheng YX, Peng D, Tao W, Zhang W. Effect of oncometabolic surgery on gastric cancer: The remission of hypertension, type 2 diabetes mellitus, and beyond. World J Gastrointest Oncol. 2021 Sep 15;13(9):1157-1163. doi:https://doi.org/10.4251/wjgo.v13.i9.1157.
23. Lee YK, Lee EK, Lee YJ, Eom BW, Yoon HM, Kim YI, Cho SJ, Lee JY, Kim CG, Kong SY, Yoo MK, Hwangbo Y, Kim YW, Choi IJ, Kim HJ, Kwak MH, Ryu KW. Metabolic Effects of Gastrectomy and Duodenal Bypass in Early Gastric Cancer Patients with T2DM: A Prospective Single-Center Cohort Study. J Clin Med. 2021 Sep 4;10(17):4008. doi:https://doi.org/10.3390/jcm10174008.
24. Kwon Y, Kwon JW, Ha J, Kim D, Cho J, Jeon SM, Park SH, Hwang J, Kim NH, Park S. Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score. Gastric Cancer. 2022 Jan;25(1):265-274. doi:https://doi.org/10.1007/s10120-021-01216-2.
25. Kwon Y, Kwon JW, Kim D, Ha J, Park SH, Hwang J, Heo Y, Park S. Predictors of Remission and Relapse of Diabetes after Conventional Gastrectomy for Gastric Cancer: Nationwide Population-Based Cohort Study. J Am Coll Surg. 2021 Jun;232(6):973-981.e2. doi:https://doi.org/10.1016/j.jamcollsurg.2021.03.019.
26. Mizukami A, Kawaguchi Y, Shoda K, Akaike H, Saito R, Maruyama S, Shiraishi K, Furuya S, Amemiya H, Kawaida H, Sudo M, Kono H, Ichikawa D. Postoperative Remission of Diabetes Mellitus After Gastrectomy in Patients With Diabetes Mellitus and Gastric Cancer. In Vivo. 2023 Nov-Dec;37(6):2808-2814. doi:https://doi.org/10.21873/invivo.13394.
27. Peng D, Cheng YX, Zhang W. Does Roux-en-Y Construction Really Bring Benefit of Type 2 Diabetes Mellitus Remission After Gastrectomy in Patients with Gastric Cancer? A Systematic Review and Meta-Analysis. Diabetes Ther. 2020 Dec;11(12):2863-2872. doi:https://doi.org/10.1007/s13300-020-00934-7.
28. Zhao L, Wei L, Fei XL. Impact of diabetes on recovery after radical gastrectomy for gastric cancer: A retrospective cohort study. World J Gastrointest Surg. 2025 Mar 27;17(3):100763. doi:https://doi.org/10.4240/wjgs.v17.i3.100763.
29. Liu ZK, Ma WX, Zhang JJ, Liu SD, Duan XL, Wang ZZ. Risk factor analysis and establishment of a predictive model for complications of elderly advanced gastric cancer with Clavien-Dindo classification ≥ II grade. BMC Cancer. 2024 Sep 27;24(1):1185. doi:https://doi.org/10.1186/s12885-024-12965-5.
30. Yu Z, Liang C, Li R, Xu Q, Gao J, Li P, Zhou S, Zhao X, Xu M, Liang W. The impact of diabetes mellitus on short and long term outcomes in patients with gastric cancer following radical surgery: a retrospective cohort study with propensity score matching. BMC Cancer. 2024 Nov 27;24(1):1461. doi:https://doi.org/10.1186/s12885-024-13232-3.
31. Ito Y, Miwa T, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Risk score for predicting death from other causes after curative gastrectomy for gastric cancer. Gastric Cancer. 2023 Mar;26(2):317-323. doi:https://doi.org/10.1007/s10120-022-01354-1.
32. Matsui R, Inaki N, Tsuji T. Impact of diabetes mellitus on long-term prognosis after gastrectomy for advanced gastric cancer: a propensity score matching analysis. Surg Today. 2022 Sep;52(9):1382-1391. doi:https://doi.org/10.1007/s00595-022-02482-y.
33. Peng D, Xiang YC, Tang KL, Qiu YY. Impact of preoperative type 2 diabetes mellitus on the outcomes of patients with gastric cancer following gastrectomy: Analysis of 834 patients using propensity score matching. Biomed Rep. 2023 Oct 19;19(6):97. doi:https://doi.org/10.3892/br.2023.1679.
34. Cheng YX, Tao W, Kang B, Liu XY, Yuan C, Zhang B, Peng D. Impact of Preoperative Type 2 Diabetes Mellitus on the Outcomes of Gastric Cancer Patients Following Gastrectomy: A Propensity Score Matching Analysis. Front Surg. 2022 Mar 8;9:850265. doi:https://doi.org/10.3389/fsurg.2022.850265.
35. Kwon Y, Kwon JW, Kim J, Kim D, Hwang J, Ha J, Park SH, Park S. Comparative Risk of Type 2 Diabetes after Gastrectomy and Endoscopic Resection for Gastric Cancer: A Nationwide Cohort Study. J Am Coll Surg. 2023 Dec 1;237(6):902-910. doi:https://doi.org/10.1097/XCS.0000000000000868.
36. Kim G, Han KD, Cho SH, Oh R, Lee YB, Jin SM, Hur KY, Kim JH. Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study. Diabetes Metab. 2024 Sep;50(5):101569. doi:https://doi.org/10.1016/j.diabet.2024.101569.
37. Lan WH, Lin TY, Yeh JA, Feng CL, Hsu JT, Lin HJ, Kuo CJ, Lai CH. Mechanism Underlying Metformin Action and Its Potential to Reduce Gastric Cancer Risk. Int J Mol Sci. 2022 Nov 16;23(22):14163. doi:https://doi.org/10.3390/ijms232214163.
38. Cunha Júnior AD, Bragagnoli AC, Costa FO, Carvalheira JBC. Repurposing metformin for the treatment of gastrointestinal cancer. World J Gastroenterol. 2021 May 7;27(17):1883-1904. doi:https://doi.org/10.3748/wjg.v27.i17.1883.
39. Cheung KS, Chung KL, Leung WK. Chemopreventive Effect of Metformin on Gastric Cancer Development. Gut Liver. 2022 Mar 15;16(2):147-156. doi:https://doi.org/10.5009/gnl210132.
40. Lu H, Han X, Ren J, Ren K, Li Z, Zhang Q. Metformin attenuates synergic effect of diabetes mellitus and Helicobacter pylori infection on gastric cancer cells proliferation by suppressing PTEN expression. J Cell Mol Med. 2021 May;25(10):4534-4542. doi:https://doi.org/10.1111/jcmm.15967.
41. Dulskas A, Patasius A, Kaceniene A, Linkeviciute-Ulinskiene D, Zabuliene L, Smailyte G. A Cohort Study of Antihyperglycemic Medication Exposure and Gastric Cancer Risk. J Clin Med. 2020 Feb 5;9(2):435. doi:https://doi.org/10.3390/jcm9020435.
42. Seo SI, Park CH, Kim TJ, Bang CS, Kim JY, Lee KJ, Kim J, Kim HH, You SC, Shin WG. Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis. Cancer Med. 2022 Feb;11(4):1217-1231. doi:https://doi.org/10.1002/cam4.4514.
43. Kao HW, Tsai KW, Lin WC. Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition. Int J Med Sci. 2023 Apr 17;20(6):717-724. doi:https://doi.org/10.7150/ijms.82407.
44. Fang CW, Yang JS, Chiang JH, Shieh PC, Tsai FJ, Tsai CW, Chang WS. Metformin induces autophagy of cisplatin-resistant human gastric cancer cells in addition to apoptosis. Biomedicine (Taipei). 2023 Jun 1;13(2):14-23. doi:https://doi.org/10.37796/2211-8039.1408.
45. Tseng CH. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature. Biomolecules. 2021 Jul 13;11(7):1022. doi:https://doi.org/10.3390/biom11071022.
46. Li L, Huang J, Huang T, Yao J, Zhang Y, Chen M, Shentu H, Lou H. Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies. Int J Endocrinol. 2023 Mar 4;2023:5892731. doi:https://doi.org/10.1155/2023/5892731.
47. Bahardoust M, Mousavi S, Moezi ZD, Yarali M, Tayebi A, Olamaeian F, Tizmaghz A. Effect of Metformin Use on Survival and Recurrence Rate of Gastric Cancer After Gastrectomy in Diabetic Patients: A Systematic Review and Meta-analysis of Observational Studies. J Gastrointest Cancer. 2024 Mar;55(1):65-76. doi:https://doi.org/10.1007/s12029-023-00955-y.
48. Chung WS, Le PH, Kuo CJ, Chen TH, Kuo CF, Chiou MJ, Chou WC, Yeh TS, Hsu JT. Impact of Metformin Use on Survival in Patients with Gastric Cancer and Diabetes Mellitus Following Gastrectomy. Cancers (Basel). 2020 Jul 23;12(8):2013. doi:https://doi.org/10.3390/cancers12082013.
49. Wang L, Hu D, Fan Z, Yu J, Zhang S, Lin Y, Chen X, Lin X, Yan X, Lin J, Peng F. Prognostic value of long-term antidiabetic and antihypertensive therapy in postoperative gastric cancer patients: the FIESTA study. BMC Gastroenterol. 2022 Oct 9;22(1):429. doi:https://doi.org/10.1186/s12876-022-02514-4.
